Previous studies have demonstrated that chronic inhibition of NHE prevents or mitigates HF in animal models [60], and this might be one of the mechanisms through which empagliflozin protects from HF deaths and hospitalizations. This evidence concerns the gene SLC9C1 and hydrops fetalis.